​Octabone® was developed as a clinically efficient alternative to Ti-oss®, which is positioned in the premium segment in terms of both quality and price.

Octabone® share the same high porosity and surface roughness as Ti-oss®, providing an optimal environment for revascularization and fibrin network formation. The key distinction lies in the distribution ratio of OCP (osteopromoting factor): while Ti-oss® is rich in OCP, Octabone® contains only a minimal or near-negligible amount on its surface.